目的 观察痰热清注射液辅助治疗小儿肺炎的临床效果.方法 对我院收住的118例肺炎患儿随机分为治疗组和对照组各59例,对照组常规应用抗感染、抗病毒、退热、止咳化痰、吸氧、改善微循环及营养支持等综合治疗,治疗组在常规治疗基础上加用痰热清注射液,qd,疗程5～10 d.结果 治疗组总愈显率93.22%,总有效率98.31%;对照组总愈显率74.58%,总有效率88.14%,2组总愈显率和总有效率比较差异有统计学意义(P＜0.05);治疗组在临床症状消失、体征明显改善、肺部阴影吸收、WBC计数恢复正常及总疗程等方面与对照组比较,差异有统计学意义(P＜0.001).结论 痰热清注射液辅助治疗小儿肺炎,能较快控制病情、改善呼吸道症状和体征、恢复正常体温,缩短疗程.其使用安全,临床疗效确切.%Objective To observe the clinical efficacy of Tanreqing injection as adjuvant therapy on infants with pneumonia. Methods 118 infants with pneumonia were randomly and evenly divided into the treatment group and the control group. All patients were given the routine application of anti-infection, antiviral cooling, cough phlegm, oxygen, improved microcirculation and nutritional support, and the treatment group was additionally treated with Tanreqing injection, qd, 5~10 d. Results The total curative rate was 93. 22% and 74. 58% , and the total effective rate was 98. 31% and 88. 14% respectively in the treatment group and in the control group, which showed a significant difference between the two groups ( P < 0. 05 ). The improvement of the disappearance of clinical symptoms, body signs, pulmonary shadow absorption, WBC counts returned to normal and duration of hospital stay was more pronounced in the treatment group than in the control group ( P < 0. 01 ). Conclusion Tanreqing injection can quickly control the patients' condition, improve the respiratory symptoms and signs, and shorten the course of treatment as adjuvant therapy on infants with pneumonia.
展开▼
